AEMPS Medicines Online Information Center - CIMAThis application includes all the medicines authorized in Spain and its purpose consists exclusively on informing to health professionals. For each medicine there is a Summary of Product Characteristics (SPC) document related. A SPC contents the description of the medicine, therapeutic indications, posology and method of administration, contraindications, special warnings and precautions for use and pharmaceutical properties.
The SPC, is the result of the scientific evaluation work carried out by The Spanish Agency of Medicines and Medical Devices (AEMPS) once the scientific information is provided by the medicine application owner. The SPC is a part of the authorization granted by the AEMPS.
The SPC content is revised and updated during the medicine¿s market life in order to include or modify the new information produced. All this updates are, also, revised and authorized by the AEMPS.
The information included in these documents is addressed mainly to health professionals. To patients or general people, the adequate information, is provided through the Product Leaflet, which is also included inside the medicine packet.
In spite all the efforts made to deliver this official information, we cannot exclude fortuitous errors or omissions, therefore you can use this page exclusively for information purposes, and has no validity for legal effects. If you desire to make any observation please contact us at: sugerencias_FT@aemps.es
The Spanish Agency of Medicines and Medical Devices is not responsible of the inadequate or illegal use of the information supplied. Those acts will be of exclusive responsibility of who made that use.
Los datos de esta aplicación son los existentes en el registro de medicamentos autorizados por la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS).
Para la puesta en el mercado de un medicamento en España es obligatoria la autorización previa por la AEMPS y la comunicación del Titular de la Autorización de Comercialización de la puesta en el mercado( Real Decreto 1345/2007)
Para reportar incidencias informáticas relativas a esta aplicación (*) envíe un correo a
sugerencias_FT@aemps.es.
(*) No se atenderán consultas médicas.
Visite http://www.aemps.gob.es/contactar/home.htm para otras direcciones de correo de la AEMPS.
© Agencia Española de Medicamentos y Productos Sanitarios